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INTRODUCTION 
Oral route is the most preferred route of administration 
of the drug due to various reasons like its convenience, 
good patient acceptance and low medicine production 
costs1. The solubility and permeability of the drug is a 
key determinant for its oral bioavailability. There have 
always been certain drugs for which solubility has 
presented a challenge for developing suitable 
formulation for oral administration2. Studies have shown 
that 40% of the new chemical entities are poorly soluble 
in water of insoluble in water and upto 50% of the orally 
administered drug compound suffer from formulation 
problem related to their low solubility and high 
lipophilicity. For a drug to be absorbed in the systemic 
circulation after the oral administration need to be 
dissolved in the gastric fluid1. However, a poorly water 
soluble drug with poor solubility and low dissolution rate 
in the aqueous gastrointestinal fluid is a reason for its 
insufficient bioavailability. Solubility of such drugs can 
be improved by incorporating the drug in a hydrophilic 
carrier material obtaining a product called solid 
dispersion3. 
In 1961, Sekiguchi and obi first proposed the utilization 
of solid dispersion inorder to increase the dissolution and 
oral absorption of poorly water soluble drugs 4. In 1971 
Chiou and Riegelman defined Solid dispersion as 
“dispersion of one or more active ingredients in an inert 
carrier or matrix at solid state prepared by the melting 
(fusion), solvent, or melting solvent method” 5. The solid 
dispersion may also be called solid state dispersion, as 
first used by Mayerson and Gibaldi 6. Solid dispersion 
has been used as an effective method to improve the 
bioavailability and dissolution rate of poorly water 
soluble drugs7. 
In the Biopharmaceutical Classification System the class 
II drugs show low aqueous solubility and high membrane 
permeability. Thus, Solid dispersion technologies give 
promising results for improving the oral absorption and 
bioavailability of the drugs belonging to BCS class II 8. 
Though salt formation, particle size reduction, 
solubilization 9, and complexation with cyclodextrin 8 
have been used to increase the dissolution rate and 
thereby the oral absorption and bioavailability of poorly 
water soluble drugs10. However these techniques have 
limitations. On the other hand, solid dispersion 
formulations offer various processing and excipients an 
option that allows more flexibility for formulating oral 
delivery system for poorly water soluble drugs 8.  
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ABSTRACT 
Biopharmaceutics Classification System is important for determining the bioavailability of the drugs. Drug development tool that 
allows estimation of the three major factors that affect oral drug absorption from immediate release solid oral dosage form is 
Dissolution, Solubility and Intestinal permeability. The bioavailability issue can be due to insufficient solubility of permeability. 
Most compounds face the solubility problems. The dissolution rate of drug from its dosage form is considered as an important 
parameter in the absorption. Dissolution is the rate-limiting step in the absorption of drugs from one solid dosage form especially 
when the drug is poorly water soluble. Poor wettability of drugs leads to the decrease in their bioavailability. Presently only 8% 
of new drug candidates have both high solubility and permeability and more than 60% of the products have poor water solubility. 
As a result the potentially important drugs do not reach the market and are not achieving their full potential. Hence, with t he 
advancement of chemical science, the need of development of pharmaceutical technologies is also increasing. Solid dispersions 
have attracted considerable interest as an efficient means of improving the dissolution rate and hence the bioavailability of  many 
drugs belonging to BCS class II. Solid dispersion has been used over last 20 to 30 years and has been known to give fruitful 
result in improving the release rate and oral bioavailability of poorly water soluble drugs. Solid dispersion with different 
polymers and at different ratios is carried out and is known to show good release when compared to the drug alone and the 
physical mixture. Improvement in dissolution of drug was observed in all the solid dispersions as compared to pure drug. 
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The solubility and bioavailability of poorly water soluble 
drug can be improved by converting the drug into 
amorphous state 11. The mechanism by which the solid 
dispersion enhances the solubility and dissolution 
involves particle size reduction to fine molecular level, 
conversion of crystalline form to amorphous form and by 
enhancing wettability
12
. 
ADVANTAGE OF SOLID DISPERSION 
i) Particles with reduced particle size 
Molecular dispersion represents the last stage of particle 
size reduction, solid dispersion uses this principle 
where the drug is molecularly dispersed in the 
dissolution medium after the dissolution of the 
carrier8. As a result high surface area is formed and 
thus increased dissolution and consequently 
improved bioavailability of poorly water soluble 
drug13. 
ii) Particles with improved wettability 
Drug solubility enhancement is related to the drug 
wettability improvement 13. The use of carriers 
without surface activity (eg. Urea) and with surface 
activity (eg. Cholic acid and bile salt) improved drug 
wettability. Moreover, carriers improve the drug 
dissolution profile by direct dissolution or co-solvent 
effect8.  
iii) Particles with high porosity 
The dissolution rate of the solid dispersion increases 
when carriers with high degree of porosity are used. 
For example solid dispersion containing linear 
polymer have larger and more porous particles and 
thus gives higher dissolution rate13.  
iv) Particles in amorphous state 
Drugs in amorphous state tend to have higher solubility 
then the drugs in crystalline state and it requires 
energy to break the crystal lattice. In solid dispersion 
the drug exists as supersaturated solution after 
system dissolution and it is considered when drug 
precipitate, it exists as a metastable polymorphic 
form with higher dissolution then the crystal form8. 
DISADVANTAGE OF SOLID DISPERSION 
The major disadvantage of solid dispersion is related to 
the instability13. During storage the effect of moisture on 
the stability of amorphous pharmaceuticals is of 
significant concern, as it increases the drug mobility and 
promotes drug crystallization. An obstacle in solid 
dispersion method in pharmaceutical development is the 
amount of carrier needed i.e. more than 50% to 80% is 
required to achieve desired dissolution. In addition the 
polymer used for solid dispersion also absorbs moisture 
which may result in phase separation, crystal growth or 
conversion to the crystalline form. Thus results in 
decreased solubility and dissolution rate 14.   
Limitations of Solid Dispersion 
i) The physical and chemical stability of drugs and 
vehicles,  
ii) Method of preparation,  
iii) Reproducibility of its physicochemical properties,14 
iv) Formulation of solid dispersion into dosage forms, 
and 
v) Scale-up of manufacturing processes13.
vi)  
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TYPES OF SOLID DISPERSION 
a) Eutectic mixtures: It consists of two completely 
miscible compounds in liquid state. However it has 
very limited miscibility in solid state. It is prepared 
by rapid solidification of fused melt of two 
components which has complete liquid miscibility.   
b) Solid solution: It consists of just one phase 
irrespective of the number of components. In solid 
solution the particle size of the drug has been 
reduced to absolute minimum and the dissolution 
rate is determined by the dissolution rate of the 
carrier.  
c) Glass solution and suspensions: Glass solutions are 
homogeneous glassy system in which solute 
dissolves in glass carrier. Glass suspensions are 
mixture in which precipitated particles are 
suspended in glass solvent. Lattice energy is much 
lower in glass solution and suspension.  
d) Amorphous precpitation in crystalline matrix: 
This is similar to simple eutectic mixtures. However 
it differs from simple eutectic mixture by that the 
drug is precipitated out in amorphous form 15.
 
 
Table 1: Types of solid dispersion (Chiou and Riegelman Classification)
17
 
S.No. Solid dispersion 
type 
Matrix Drug Observation No. of 
Phases 
1. Eutectics Crystalline 
stare 
Drug dispersed as crystalline 
particles in the matrix 
The first type of solid 
dispersion prepared 
2 
2. Amorphous 
precipitation in 
crystalline matrix 
Crystalline 
state 
A drug dispersed as 
amorphous clusters in the 
matrix 
Rarely encountered 2 
3. Solid solution - - - - 
Continuous solid 
solution 
Crystalline 
state 
Drug molecularly dispersed 
throughout the matrix 
Miscible at all composition, 
never prepared 
1 
Discontinuous 
solid solution 
Crystalline 
state 
Drug molecularly dispersed 
throughout the matrix 
Partially miscible, 2 phases 
even though drug is 
molecularly dispersed 
2 
Substitutional solid 
solution 
Crystalline 
state 
Drug molecularly dispersed 
throughout the matrix 
Molecular diameter of drug 
(solute) differ less than 15% 
from the matrix (solvent) 
diameter 
1 or 2 
Interstitial solid 
solution 
Crystalline 
state 
Drug molecularly dispersed 
throughout the matrix 
Drug molecular diameter less 
than 59% of matrix diameter. 
Usually limited miscibility, 
Discontinuous. Example: Drug 
in helical interstitial space of 
PEG 
2 
4. Glass suspension Amorphous 
state 
A drug dispersed as 
amorphous clusters in the 
matrix 
Particle size of dispersed phase 
dependent on cooling/ 
evaporation rate many solid 
dispersion are of this type 
2 
5. Glass Solution Amorphous 
state 
Drug molecularly dispersed 
throughout the matrix 
Requires miscibility/ solid 
solubility or complex formation 
on fast cooling or evaporation 
during preparation, many 
example especially with PVP 
1 
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METHODS OF SOLID DISPERSION  
a) Fusion method:  it is also known as melt method 
when the starting materials used are crystalline13. 
Sekiguchi et al. in 1961 were the first to use melting 
method which involved melting the drug within the 
carrier followed by cooling and pulverization of the 
obtained product
17
. Ex. Albendazole and urea solid 
dispersion was prepared by this method18. The main 
advantages of this method are its simplicity and 
economy. is However it has few limitations like it is 
applied only when the drug and the matrix are 
compatible and when they mix well at the heating 
temperature. Phase separation may also occur during 
cooling, the drug matrix miscibility changes13. 
b) Solvent Evaporation method: the drug and the 
carrier are completely dissolved in an organic 
solvent, the solvent is evaporated. The obtained 
solid mass is ground, sieved and dried. Ex. Solid 
dispersion of ofloxacin with PEG by solvent 
evaporation method16. 
c) Modified Solvent Evaporation method: drug is 
dissolved in organic solvent at its saturation 
solubility with continuous stirring for some time. 
The polymer is suspended in sufficient amount of 
water. The drug solution is poured at once into 
polymer suspension. The entire solvent is 
evaporated. The mass obtained is dried16. 
d) Melting Solvent method: it is a combination of two 
methods which involves dissolving the drug in a 
suitable solvent and mixing it with molten carrier 
followed by cooling15. The solidified mass is 
crushed, pulverized and passed through sieve. The 
advantage of this method is it reduces maximum 
temperature and results in less decomposition of 
thermolabile drugs. 
e) Kneading method: A mixture of accurately 
weighed drug and carrier is wetted with solvent and 
kneaded thoroughly for some time in a glass mortar. 
The paste formed is dried and sieved. Ex. 
furosemide and crospovidone solid dispersion was 
prepared by this method 19. 
f) Co-grinding: the drug and carriers physical mixture 
is mixed in a blender at a particular speed. It is then 
charged into a chamber of vibration ball mill. The 
powder mixture is pulverized and collected at room 
temperature. Ex chlordiazepoxide and mannitol solid 
dispersion was prepared by this method18. 
g) Co-precipitation method: the carrier is dissolved in 
water and drug in organic solvent, then the aqueous 
solution of carried is poured into organic solution of 
drug. During the addition of non-solvent the drug 
and carrier are co-precipitated to form micro 
particles. The resultant micro particle suspension is 
filtered and dried (solid dispersion) 20. 
h) Spray drying method:  here the solution of drug 
substance and carrier is evaporated by spraying the 
solution as fine droplets in chamber with maintained 
temperature, humidity and airflow. The principle 
involved is evaporation of the solvent from the 
mixture until the desired moisture content is 
obtained. It is advantageous for weight and volume 
reduction 15. Rankell et al. prepared solid dispersion 
of Loperamide with PEG 6000 21. 
i) Direct capsule filling: filling of semisolid material 
in to and hard gelatin capsule as melt, this method 
was first described by Francois and Jones15. The 
molten dispersion forms a solid plug inside the 
capsule on cooling at room temperature. This 
method is advantageous as it reduces cross 
contamination, exposure in dust free environment, 
better filling and content uniformity can be 
obtained20 
j) Lyophillization technique: it has been thought of a 
molecular mixing technique where the drug and 
carrier are co dissolved in a common solvent, frozen 
and sublimed to obtain a lyophilized molecular 
dispersion21.  
k) Gel entrapment technique: polymer like HPMC is 
dissolved in an organic solvent until clear and 
transparent gel is obtained. The drug is then added to 
the gel and sonicated for few minutes. The organic 
solvent is evaporated the solid dispersion obtained is 
reduced in size and sieved 22.  
 
CARRIERS FOR SOLID DISPERSION 
Carriers play an important role in influencing the 
dissolution characteristic of dispersed drug. The carrier 
needs to meet the following requirement. 
Freely soluble in water and with rapid dissolution 
property. 
Soluble in wide variety of solvents 
Chemically compatible with the drug 
Heat stable with low melting point for melt method.23 
Non toxic and pharmacologically inert 24. 
First generation carriers: Crystalline carriers: Urea, 
Sugars, and Organic acids. They have disadvantage of 
forming crystalline solid dispersion that is 
thermodynamically more stable and do not release the 
drug quickly 24. 
Second generation carriers: Amorphous carriers: 
Polyethylene glycol, Povidone, Polyvinylacetate, 
Polymethacrylate, cellulose derivatives 25. 
Third generation carriers: Surface active self 
emulsifying carriers: Poloxamer 408, Tween 80, 
Gelucire 44/14. These carriers have been effective in 
originating high polymorphic purity and enhanced in 
vivo bioavailability25.  
CHARACTERIZATION OF SOLID DISPERSION 
a) Physical characterization and saturation 
solubility 
An excess amount of the physical mixture and solid 
dispersion is taken in a conical flask and 10 ml of 
distilled water is added and shaken on rotator shaker 
for 48 hour at 37°C. Remove the flask and filter it. 
Suitable amount of aliquot is withdrawn from the 
filtered solution and the drug content was analyzed 
after appropriate dilution with distilled water and 
was compared with pure drug solubility 26. 
b) Fourier Transform Infrared Spectroscopic 
Analysis 
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The interaction between the drug and the carrier in 
solid dispersion is assessed by FTIR. In the solid 
dispersion preparation the peak band shows shift in 
the absorption spectrum for the drug molecule. 
However, Careful interpretation of the spectrum is 
required for some of the delicate changes27 
c) Differential Scanning Calorimetry 
The calibration of the DSC temperature and 
enthalpy scale was carried out using Indium/Zinc 
standards. The sample are taken in an aluminum pan 
and is hermetically sealed and heated at a constant 
rate of 20°C per minute over a temperature range of 
20 to 150°C. The inert atmosphere was maintained 
by purging nitrogen gas at flow rate of 50ml/min 28.  
d) Hyper Differential Scanning Calorimetry (Hyper 
DSC) 
 This method employs excess heating rate starting 
from 100 to 500° C/min. However, in DSC the 
heating rate ranges from about 1 to 20 ° C/min. 
Hyper differential scanning calorimetry have 
number of advantages, which involves its use to 
prevent recrystalisation during the heating step. 
Hyper DSC when compared to the standard DSC 
thermograms can also be used to enhance thermal 
signals it also have advantage of minimizing and 
preventing the changes in morphology and 
interaction during the heating process29        
e) X Ray Powder Diffraction (XRPD)  
To characterize the physical form of the drug in the 
sample X ray diffraction study is carried out. In this 
method the sample is spread on a glass slide with an 
appropriate thickness of 0.5mm. The slide is then 
placed in X-ray diffractometer vertically at 0° angle 
so that the x-ray beams falls on it. The results were 
then recorded over an range of 0 to 90°C30.  
f) Scanning electron microscopy 
In this method both the pure drug and the solid 
dispersion sample and mounted on the stub using 
double sided adhesive tape and coated with gold 
palladium alloy. The samples are then analyzed 
using scanning electron microscope for external 
morphology 31. 
g) In Vitro release Studies 
 The dissolution a study is carried out using 
accurately weighed amount of sample. The sample is 
withdrawn at predetermined time interval and same 
amount of aliquots is replaced by fresh dissolution 
medium. The drug release was then analyzed UV 
spectrophotometrically or HPLC 32.   
h) Isothermal titration calorimetry (ITC) 
 It is important method for understanding biological 
processes at molecular level. In this method a small 
change of heat during the reaction can be detected. 
This method is also useful in determining 
thermodynamic parameters like Gibbs free energy, 
enthalpy, entropy, binding constant, heat capacity 
and effective numbers of binding site in the 
biological reaction. This method has advantages like 
it is the only technique that can establish all binding 
site in the biological reaction. It also allows the 
measurement of heat signals29. 
 
 
Several Marketed and late stage drugs are designed for improved solubility by solid dispersion 
 
a Halted in phase III; b Withdrawn from market. 
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CURRENT CHALLENGES AND FUTURE 
PROSPECTS 
Despite many advantages of solid dispersion, issues 
related to preparation, reproducibility, formulation, scale 
up, and stability limited its use in commercial dosage 
forms for poorly water soluble drugs. Successful 
development of solid dispersion systems for preclinical, 
clinical, and commercial use has been feasible in recent 
years due to the availability of surface-active and self-
emulsifying carriers with relatively low melting points. 
Because of the simplicity of manufacturing and scale up 
processes, the physicochemical properties and, as a 
result, the bioavailabilities of solid dispersions are not 
expected to change significantly during the scale up. For 
this reason, the popularity of the solid dispersion system 
to solve difficult bioavailability issues with respect to 
poorly water-soluble drugs will grow rapidly. One major 
focus of future research will be the identification of new 
surface-active and self-emulsifying carriers for solid 
dispersions. Only a small number of such carriers are 
currently available for oral use. 
One limitation in the development of solid dispersion 
systems may the inadequate drug solubility in carriers, so 
a wider choice of carriers will increase the success of 
dosage form development. Research should also be 
directed toward identification of vehicles or excipients 
that would retard or prevent crystallization of drugs from 
supersaturated systems. Attention must also be given to 
any physiological and pharmacological effects of carriers 
used. Many of the surface-active and self-emulsifying 
carriers are lipidic in nature, so potential roles of such 
carriers on drug absorption, especially on their inhibitory 
effects on CYP3-based drug metabolism and p-
glycoprotein-mediated drug efflux, will require careful 
consideration. 
Physical and chemical stability of both the drug and the 
carrier in a solid dispersion are major developmental 
issues so future research needs to be directed to address 
various stability issues. Although, as mentioned earlier, 
the direct filling of solid dispersion into hard gelatin 
capsules is a relatively simple process, there are very 
limited reports on the scale up of the technology. Further 
studies on scale up and validation of the process will be 
essential. Many problems and challenges still remain 
with solid dispersion systems. Nevertheless, as a result of 
recent breakthroughs, it will continue to be one of the 
exciting frontiers of drug development. 
CONCLUSION 
Due to the advantageous features of solid dispersions 
formulation scientists consider it as one of the most 
potential method of improving oral bioavailability. But 
changes in crystal behavior of drug and/or carrier 
particles during processing and storage limits the method 
to be commercially applicable.Manufacturing of solid 
dispersions requires a perfect combination of drug to 
carrier(s). Carrier molecules play the most important role 
in enhancing solubility of the resultant dispersion and 
hence improvement in oral bioavailability. Whatever this 
technology is also highly potential to formulate 
controlled release dosage forms as the carriers may 
enhance or delay drug release.  
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